Design, Synthesis, and Pharmacology of a Highly Subtype-Selective GluR1/2 Agonist, (<i>RS</i>)-2-Amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic Acid (Cl-HIBO)
Esben Jannik Bjerrum(University of Copenhagen), Ulf Madsen(NeuroSearch (Denmark)), Anders S. Kristensen(Unknown), Tommy Liljefors(Schools of Visual Arts, The Royal Danish Academy of Fine Arts), Jeremy R. Greenwood(Schrodinger (United States)), Darryl S. Pickering(University of Copenhagen), Birgitte Nielsen(Kyoto University), Hans Bräuner‐Osborne(University of Copenhagen), Arne Schousboe(University of Copenhagen)
Cited by 43
Related Papers
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
|Journal of the American Chemical Society|2015|1.4k
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
|Journal of Medicinal Chemistry|2000|525
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors
|Nature Communications|2012|483
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
|Journal of Chemical Information and Modeling|2014|465